These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 23657220)
1. Expression of endoglin (CD105) and endothelial nitric oxide synthase in head and neck arteriovenous malformations. Hou F; Dai Y; Dornhoffer JR; Suen JY; Fan CY; Saad AG; Buckmiller LM; Richter GT JAMA Otolaryngol Head Neck Surg; 2013 Mar; 139(3):237-43. PubMed ID: 23657220 [TBL] [Abstract][Full Text] [Related]
2. Endothelial cells of oral pyogenic granulomas express eNOS and CD105/endoglin: an immunohistochemical study. Vassilopoulos SI; Tosios KI; Panis VG; Vrotsos JA J Oral Pathol Med; 2011 Apr; 40(4):345-51. PubMed ID: 21073538 [TBL] [Abstract][Full Text] [Related]
3. Atorvastatin-induced endothelial nitric oxide synthase expression in endothelial cells is mediated by endoglin. Zemankova L; Varejckova M; Dolezalova E; Fikrova P; Jezkova K; Rathouska J; Cerveny L; Botella LM; Bernabeu C; Nemeckova I; Nachtigal P J Physiol Pharmacol; 2015 Jun; 66(3):403-13. PubMed ID: 26084222 [TBL] [Abstract][Full Text] [Related]
4. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Toporsian M; Gros R; Kabir MG; Vera S; Govindaraju K; Eidelman DH; Husain M; Letarte M Circ Res; 2005 Apr; 96(6):684-92. PubMed ID: 15718503 [TBL] [Abstract][Full Text] [Related]
5. Analysis of endoglin expression in normal brain tissue and in cerebral arteriovenous malformations. Matsubara S; Bourdeau A; terBrugge KG; Wallace C; Letarte M Stroke; 2000 Nov; 31(11):2653-60. PubMed ID: 11062290 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas. Netto GC; Bleil CB; Hilbig A; Coutinho LM Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma. Raica M; Cimpean AM; Anghel A Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316 [TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence. Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of arteriovenous malformations in the absence of endoglin. Mahmoud M; Allinson KR; Zhai Z; Oakenfull R; Ghandi P; Adams RH; Fruttiger M; Arthur HM Circ Res; 2010 Apr; 106(8):1425-33. PubMed ID: 20224041 [TBL] [Abstract][Full Text] [Related]
10. Abnormal pattern of Tie-2 and vascular endothelial growth factor receptor expression in human cerebral arteriovenous malformations. Hashimoto T; Emala CW; Joshi S; Mesa-Tejada R; Quick CM; Feng L; Libow A; Marchuk DA; Young WL Neurosurgery; 2000 Oct; 47(4):910-8; discussion 918-9. PubMed ID: 11014431 [TBL] [Abstract][Full Text] [Related]
11. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma]. Li Q; Zhang B; Peng P Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257 [TBL] [Abstract][Full Text] [Related]
15. Endoglin increases eNOS expression by modulating Smad2 protein levels and Smad2-dependent TGF-beta signaling. Santibanez JF; Letamendia A; Perez-Barriocanal F; Silvestri C; Saura M; Vary CP; Lopez-Novoa JM; Attisano L; Bernabeu C J Cell Physiol; 2007 Feb; 210(2):456-68. PubMed ID: 17058229 [TBL] [Abstract][Full Text] [Related]
16. Soluble endoglin modulates aberrant cerebral vascular remodeling. Chen Y; Hao Q; Kim H; Su H; Letarte M; Karumanchi SA; Lawton MT; Barbaro NM; Yang GY; Young WL Ann Neurol; 2009 Jul; 66(1):19-27. PubMed ID: 19670444 [TBL] [Abstract][Full Text] [Related]
17. Endoglin (cd105) and S100A13 as markers of active angiogenesis in endometriosis. Hayrabedyan S; Kyurkchiev S; Kehayov I Reprod Biol; 2005 Mar; 5(1):51-67. PubMed ID: 15821778 [TBL] [Abstract][Full Text] [Related]
18. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF. Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868 [TBL] [Abstract][Full Text] [Related]
19. Endoglin (CD105) expression in head and neck basaloid squamous cell carcinoma. Marioni G; Gaio E; Giacomelli L; Marchese-Ragona R; Staffieri C; Staffieri A; Marino F Acta Otolaryngol; 2005 Mar; 125(3):307-11. PubMed ID: 15966703 [TBL] [Abstract][Full Text] [Related]
20. Endoglin (CD105) expression on microvessel endothelial cells in juvenile nasopharyngeal angiofibroma: tissue microarray analysis and association with prognostic significance. Wang JJ; Sun XC; Hu L; Liu ZF; Yu HP; Li H; Wang SY; Wang DH Head Neck; 2013 Dec; 35(12):1719-25. PubMed ID: 23471755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]